★ Sign in to follow
GT

Guard Therapeutics AB Stock: price and insider trades · Sweden

ISIN SE0009973357SE·

No insider purchase over the last 90 days. The latest, by Hege Hellstrom, was filed 24 Jul 2024.

Guard Therapeutics AB: what insiders have been doing

Guard Therapeutics AB is a listed company. Filings by its managers are published through Finansinspektionen. The past year has been quiet: not a single insider filing for Guard Therapeutics AB. The previous disclosure was published on 24 July 2024.

Our records for Guard Therapeutics AB go back to 2019, with 6 purchases and no sales on the open market in total.

For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Insider Decl.
10
Thresholds
n/a
Buy Volume
€69,973
6 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 24 July 2024
Declarations10 total
  • ▲
    Hege Hellstrom
    StyrelseledamotExecutives
    89,730 SEK15FI-SE
    3,000 shares@ SEK 29.91100.0% of flowAktieISIN SE0009973357FI:csv-9ba26a9d97a1036e4040
    Canonical exit: 20 Oct 2024 (T+90)
  • ◆
    Torbjörn Larsson
    Annan ledande befattningshavareExecutives
    0FI-SE
    450,000 shares0OptionFI:csv-753071514cde0a35f458
  • ▲
    Pia Gideon
    StyrelseledamotExecutives
    110,666 SEK15FI-SE
    81,486 shares@ SEK 1.3581100.0% of flowAktieISIN SE0009973357FI:csv-f92f7ab10f7610aebc32
    Canonical exit: 7 Feb 2022 (T+90)
  • ◆
    Jan Wilpshaar
    Annan ledande befattningshavareExecutives
    1M SEK0FI-SE
    425,000 shares@ SEK 2.83100.0% of flowOptionFI:csv-f7b72c88f034998caccb
  • ◆
    Ann-Kristin Lena Myde
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
    0FI-SE
    875,000 shares0OptionFI:csv-4c7312d0a3c27fef295f
  • ◆
    Peter Gilmour
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
    0FI-SE
    875,000 shares0OptionFI:csv-84ee4be4c3b1cd9f6c4b
  • ▲
    Karin Maria Botha
    Ekonomichef/finanschef/finansdirektörExecutives
    70,589 SEK27FI-SE
    45,000 shares@ SEK 1.5686100.0% of flowAktieISIN SE0009973357FI:csv-d238186af2d08884251d
    Canonical exit: 8 Jul 2021 (T+90)
  • ▲
    Lars Höckenström
    Styrelseledamot/suppleantExecutives
    30,168 SEK15FI-SE
    20,000 shares@ SEK 1.5084100.0% of flowAktieISIN SE0009973357FI:csv-46b5ceee352a92428103
    Canonical exit: 27 Dec 2020 (T+90)
  • ▲
    Torun Labedzki
    Ekonomi/finanschefExecutives
    34,650 SEK27FI-SE
    30,000 shares@ SEK 1.155100.0% of flowAktieISIN SE0009973357FI:csv-f496036684612f2338c6
    Canonical exit: 3 Jun 2020 (T+90)
  • ▲
    Tobias Larsson Agervald
    VDExecutives
    400,000 SEK0FI-SE
    2,105,263 shares@ SEK 0.19100.0% of flowSyntetisk optionISIN SE0009973357FI:csv-488fe8d0bc02998051ce
    Canonical exit: 13 May 2019 (T+90)

10 of 10 declarations

About Guard Therapeutics AB

Guard Therapeutics AB is a biopharmaceutical company focused on developing treatments for kidney diseases. It is listed on the Stockholm Stock Exchange under the symbol XSTO.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations

Related companies and executives

No related entities found.